Sinopharm Chairman Liu Jingzhen told state broadcaster CCTV the company expects to finish late-stage human testing within about three months.Sinopharm's experimental shot has entered a Phase III trial involving around 15,000 participants and two vaccine strains in the United Arab Emirates
from Livemint - Science https://ift.tt/2CvptPm
https://ift.tt/eA8V8J
from Livemint - Science https://ift.tt/2CvptPm
https://ift.tt/eA8V8J
Post a Comment